The Roy Castle Lung Cancer Foundation

The Liverpool Lung Project and the wider research portfolio if the Roy Castle Lung Cancer Research Programme has received funding from the Roy Castle Lung Cancer Foundation since 1998. We are proud of our association with the only dedicated lung cancer charity in the UK and fully support its aim to save lives and support people affected by lung cancer.

UK Funding

Our research is funded by leading charity both national (e.g. Cancer Research UK) and local (e.g. North West Cancer Research). LLP has received finding from NHS trusts including: Knowsley, Sefton and Liverpool Primary Care Trusts, Liverpool Clinical Commissioning Group and the National Institute for Health Research (via the Merseyside and Cheshire Cancer Network and the NIHR Clinical Research Network: North West Coast). The UKLS trial was funded by the Department of Health – Health Technology Agency.

International Funding

Internationally, we contribute to multi-centre, coordinated efforts to investigate disease risk factors, early detection and prevention strategies, genetic predisposition and cancer-related mutation. These have been funded through peer-reviewed grants from:
  • National Institute of Health (USA) – Transdisciplinary Research in Cancer of the Lung (TRICL); International Lung Cancer Consortium (ILCCO); Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL).
  • International Association for Research on Cancer – SYNERGY project
  • EU Framework 5 – European Early Lung Cancer (EUELC) Project
  • EU Framework 7 – CURELUNG: The (epi)genetics of Lung Cancer
  • EU Framework 7 – LCAOS: A Nanoscale Artificial Nose to easily detect Volatile Biomarkers at Early stages of Lung Cancer and Related Genetic Mutations

Commercial

We also collaborate with a number of industrial partners who support us through technology access, development funding or academic partnership.